6 times when drug development got personal
While biopharma’s overarching mission is to develop innovative medicines to improve patient outcomes, for these six people, the motivation came from much closer to home.
Uncategorized
Judge vacates most of controversial 2025 ACA enrollment, eligibility rule
Friday’s decision is a victory for insurance advocates. But, given many of the rule’s provisions were codified in the GOP’s “Big Beautiful Bill,” it’s not a panacea for the ACA.
Judge vacates most of controversial 2025 ACA enrollment, eligibility rule Read More »
Medicare drug price rule may target under-the-skin cancer immunotherapies
For 2029, a federal rule proposes closing a “loophole” that protects medicines transitioning from intravenous administration from price protection.
Medicare drug price rule may target under-the-skin cancer immunotherapies Read More »
In a first, Dexcom’s OTC glucose sensor is cleared for kids
The Stelo over-the-counter glucose monitor can now be used by children as young as two years.
In a first, Dexcom’s OTC glucose sensor is cleared for kids Read More »
Medtronic closes Scientia Vascular takeover, continuing M&A streak
CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”
Medtronic closes Scientia Vascular takeover, continuing M&A streak Read More »
Elicio crashes on midstage pancreatic cancer miss but will advance to Phase 3
Elicio Therapeutics’ investigational cancer immunotherapy failed to meet the primary endpoint of disease-free survival in a Phase 2 trial—a result the company attributed mostly to a disproportionate number of patients with higher residual disease.
Elicio crashes on midstage pancreatic cancer miss but will advance to Phase 3 Read More »
Germany rethinking drug price reforms after Lilly, Boehringer withdraw investments: Reuters
Weeks after Boehringer Ingelheim and Eli Lilly retracted billions of dollar in German commitments, the nation’s government is reportedly changing a contentious element of its planned healthcare reforms.
Neumora discards depression asset, lays off staffers after pair of late-stage flops
Neumora Therapeutics is laying off 35% of workers after its most advanced asset failed a pair of Phase 3 studies, sending the biotech’s stock spiraling early Monday.
Neumora discards depression asset, lays off staffers after pair of late-stage flops Read More »
Inteligencia artificial diagnosticando tumores cerebrales en minutos en vez de en semanas
Los tumores de cerebro y de médula espinal son extremadamente diversos. En los últimos años, se ha evidenciado que muchos de estos tumores solo pueden diagnosticarse con precisión si se examinan sus propiedades moleculares, además de su apariencia microscópi …
Descubren el cuásar parpadeante más antiguo
Típicamente, un agujero negro supermasivo se encuentra en el corazón de cada galaxia, incluida la Vía Láctea. Cuando un agujero negro está activo, o sea succionando cantidades significativas de materia, se forma a su alrededor un remolino de gas y polvo a alta temp …